Almuqate 2018.

Study characteristics
Study design	Cohort
Study setting	Setting: University of Calgary Country: Canada Dates: tumour samples were tested for MGMT methylation in 2015 and 2016.
Selection of participants	Cases were retrieved from the Molecular Diagnostic Laboratory database.
Participant characteristics	Sample size: 158 (deaths: NR) Age: mean 61 years Sex: 53.8% men KPS: NR
Tumour characteristics	GBM: 100% First diagnosis: NR Biopsy: 8.9%; subtotal resection: 38%; total resection: 53.2% IDH1 wild‐type: NR; IDH2 wild‐type: NR
Treatment regimen	NR
MGMT promoter methylation tests implemented	MS‐RE‐qPCR
Dates and follow‐up	Timing of MGMT assessment: at diagnosis Start time for follow‐up: NR; follow‐up: median NR; range NR
Notes